Targeted Cancer Therapies
Targeted Cancer Therapies
Pharmacogenomics: Identification of New Drug Targets
Combination Therapies and Personalized Medicine
Drug Discovery: Overview
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 9, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Dharmendra Kumar Yadav1, Desh Deepak Singh2, Dongyun Shin1
1College of Pharmacy, Gachon University, Hambakmoeiro 191, Yeonsu-gu, Incheon 21924, Republic of Korea.
Molecular-targeted cancer therapies block key molecules for tumor growth, offering improved efficacy and fewer side effects. This review covers strategies like angiogenesis inhibition and targeting cell division for innovative cancer medicine development.
09:33Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: